Hiroki Ishibashi Selected Research

Placenta Previa

1/2021	Criteria for placenta accreta spectrum in the International Federation of Gynaecology and Obstetrics classification, and topographic invasion area are associated with massive hemorrhage in patients with placenta previa.
12/2020	The use of magnetic resonance imaging to predict placenta previa with placenta accreta spectrum.
9/2020	Placenta previa may acquire invasive nature by factors associated with epithelial-mesenchymal transition and matrix metalloproteinases.
1/2019	Analysis of prophylactic Bakri balloon tamponade failure in patients with placenta previa.
10/2017	Cervical varicosities may predict placenta accreta in posterior placenta previa: a magnetic resonance imaging study.
8/2017	Pregnancy with asymptomatic uterine complete rupture after uterine artery embolization for postpartum hemorrhage.
1/2017	Effect of routine rapid insertion of Bakri balloon tamponade on reducing hemorrhage from placenta previa during and after cesarean section.
1/2016	Relation between Birth Weight and Intraoperative Hemorrhage during Cesarean Section in Pregnancy with Placenta Previa.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hiroki Ishibashi Research Topics

Disease

16	Neoplasms (Cancer) 12/2022 - 02/2011
8	Placenta Previa 01/2021 - 01/2016
6	Hemorrhage 11/2021 - 01/2016
5	Pancreaticobiliary Maljunction 02/2022 - 01/2013
5	Carcinogenesis 01/2021 - 02/2011
4	Carcinoma (Carcinomatosis) 12/2022 - 01/2018
3	Postpartum Hemorrhage 11/2021 - 08/2017
2	Biliary Tract Neoplasms (Biliary Tract Cancer) 02/2022 - 01/2021
2	Endometrial Neoplasms (Endometrial Cancer) 04/2021 - 01/2019
2	Ovarian Neoplasms (Ovarian Cancer) 01/2020 - 01/2018
2	Hypersensitivity (Allergy) 01/2018 - 07/2017
2	Uterine Rupture 12/2017 - 08/2017
2	Birth Weight (Birth Weights) 01/2016 - 01/2014
2	Ischemia 12/2014 - 09/2002
2	Hepatocellular Carcinoma (Hepatoma) 06/2014 - 02/2005
1	Choledochal Cyst (Choledochal Cysts) 02/2022
1	Deglutition Disorders (Dysphagia) 01/2022
1	Ascites 01/2022
1	Fistula 01/2022
1	Respiratory Insufficiency (Respiratory Failure) 01/2022
1	Tracheoesophageal Fistula 01/2022
1	Esophageal Atresia 01/2022
1	Ovarian Epithelial Carcinoma 09/2021
1	Mucinous Adenocarcinoma (Mucinous Carcinoma) 02/2021
1	Hemorrhagic Shock 01/2021
1	Placenta Accreta 09/2020
1	Endometriosis 05/2020
1	Endometrioid Carcinoma 04/2020
1	Latex Hypersensitivity (Latex Allergy) 01/2018
1	Anaphylaxis (Anaphylactic Shock) 01/2018
1	Rupture 08/2017
1	Postoperative Hemorrhage 01/2017
1	Prolapse 01/2017
1	Biliary Atresia 01/2016
1	Atrophy 01/2016
1	Fibrosis (Cirrhosis) 01/2016
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2016
1	Fetal Weight 01/2016
1	Reperfusion Injury 12/2014
1	Non-alcoholic Fatty Liver Disease 12/2014
1	Insulin Resistance 06/2014

Drug/Important Bio-Agent (IBA)

5	phytobacteriomycin (PBM)IBA 02/2022 - 01/2013
4	Biomarkers (Surrogate Marker)IBA 09/2021 - 01/2019
3	Proteins (Proteins, Gene)FDA Link 12/2022 - 02/2014
3	PlatinumIBA 02/2022 - 01/2018
3	Bevacizumab (Avastin)FDA Link 02/2022 - 01/2018
2	Hemoglobins (Hemoglobin)IBA 11/2021 - 01/2021
2	Paclitaxel (Taxol)FDA LinkGeneric 09/2021 - 07/2017
2	MesothelinIBA 04/2021 - 10/2020
2	CA-125 Antigen (CA 125 Antigen)IBA 04/2021 - 10/2020
2	Methionine (L-Methionine)FDA Link 01/2021 - 12/2014
2	Gemcitabine FDA Link 01/2020 - 01/2018
2	Hemostatics (Antihemorrhagics)IBA 01/2017 - 01/2016
1	LigandsIBA 12/2022
1	Starch (Cornstarch)IBA 11/2021
1	Carboplatin (JM8)FDA LinkGeneric 09/2021
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2021
1	Human Serum Albumin FDA LinkGeneric 01/2021
1	Branched-Chain Amino AcidsIBA 01/2021
1	Lysophosphatidylcholines (Lysophosphatidylcholine)IBA 01/2021
1	Matrix Metalloproteinases (MMPs)IBA 09/2020
1	Cadherins (E-Cadherin)IBA 09/2020
1	VimentinIBA 09/2020
1	3-aminopropyl-N'-methylisothioureaIBA 05/2020
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020
1	phenoxodiolIBA 01/2018
1	Cisplatin (Platino)FDA LinkGeneric 01/2018
1	Immunoglobulin E (IgE)IBA 01/2018
1	SolutionsIBA 01/2018
1	LatexIBA 01/2018
1	Rubber (Elastica)IBA 01/2018
1	Generic DrugsIBA 07/2017
1	Indicators and Reagents (Reagents)IBA 01/2016
1	12,13- dihydro- N- methyl- 6,11,13- trioxo- 5H- benzo(4,5)cyclohepta(1,2- b)naphthalen- 5,12- imineIBA 01/2016
1	Toll-Like Receptor 4IBA 01/2016
1	Peptides (Polypeptides)IBA 12/2014
1	Choline (Choline Chloride)IBA 12/2014
1	salicylhydroxamic acid (SHAM)IBA 06/2014
1	Glucagon-Like Peptide 1 (GLP 1)IBA 06/2014
1	MicroRNAs (MicroRNA)IBA 06/2014

Therapy/Procedure

11	Cesarean Section (Caesarean Section) 11/2021 - 01/2014
7	Therapeutics 02/2022 - 02/2011
3	Drug Therapy (Chemotherapy) 09/2021 - 05/2014
2	Hysterectomy 04/2021 - 10/2020
2	Salpingo-oophorectomy 04/2021 - 10/2020
2	Ligation 01/2021 - 01/2016
2	Uterine Artery Embolization 08/2018 - 08/2017
1	Pancreaticoduodenectomy 02/2022
1	Cannula 01/2022
1	Artificial Respiration (Mechanical Ventilation) 01/2022
1	Tracheostomy 01/2022
1	Tracheotomy 01/2022
1	General Anesthesia 01/2022
1	Resuscitation 01/2021
1	Erythrocyte Transfusion 01/2021
1	Surgical Hemostasis 01/2021
1	Blood Transfusion (Blood Transfusions) 08/2018
1	Premedication 07/2017
1	Oral Administration 01/2016
1	Kampo Medicine (Kampo) 01/2016